American manufacturing arm of the Chinese contract research and development company Pharmaron, based at Coventry in Rhode Island, which the group bought from Noramco in 2022 as its first active ingredient plant in the United States. The site has made active pharmaceutical ingredients to good manufacturing practice since its days as the Rhodes Technologies plant, works from pilot kilogram to commercial tonne scale with reactors from fifty to eight thousand litres, is approved by the American regulator for controlled substances, and specialises in large scale hydrogenation.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen